These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37395536)

  • 1. Chemical Evolution of Amphiphilic Xenopeptides for Potentiated Cas9 Ribonucleoprotein Delivery.
    Lin Y; Luo X; Burghardt T; Dorrer S; Höhn M; Wagner E; Lächelt U
    J Am Chem Soc; 2023 Jul; 145(28):15171-15179. PubMed ID: 37395536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipo-Xenopeptide Polyplexes for CRISPR/Cas9 based Gene editing at ultra-low dose.
    Germer J; Lessl AL; Pöhmerer J; Grau M; Weidinger E; Höhn M; Yazdi M; Cappelluti MA; Lombardo A; Lächelt U; Wagner E
    J Control Release; 2024 Jun; 370():239-255. PubMed ID: 38663751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing.
    Dubey S; Chen Z; Jiang YJ; Talis A; Molotkov A; Ali A; Mintz A; Momen-Heravi F
    Theranostics; 2024; 14(7):2777-2793. PubMed ID: 38773978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
    Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
    ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical and Functional Characterization of Differential CRISPR-Cas9 Ribonucleoprotein Complexes.
    Camperi J; Moshref M; Dai L; Lee HY
    Anal Chem; 2022 Jan; 94(2):1432-1440. PubMed ID: 34958212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR-Cas ribonucleoprotein mediated homology-directed repair for efficient targeted genome editing in microalgae
    Naduthodi MIS; Mohanraju P; Südfeld C; D'Adamo S; Barbosa MJ; van der Oost J
    Biotechnol Biofuels; 2019; 12():66. PubMed ID: 30962821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome Editing in Chlamydomonas reinhardtii Using Cas9-gRNA Ribonucleoprotein Complex: A Step-by-Step Guide.
    Dhokane D; Kancharla N; Savarimuthu A; Bhadra B; Bandyopadhyay A; Dasgupta S
    Methods Mol Biol; 2023; 2653():207-217. PubMed ID: 36995629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A qPCR Method to Assay Endonuclease Activity of Cas9-sgRNA Ribonucleoprotein Complexes.
    Nguyen MT; Kim SA; Cheng YY; Hong SH; Jin YS; Han NS
    J Microbiol Biotechnol; 2023 Sep; 33(9):1228-1237. PubMed ID: 37415091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a pVEC peptide-based ribonucleoprotein (RNP) delivery system for genome editing using CRISPR/Cas9 in Chlamydomonas reinhardtii.
    Kang S; Jeon S; Kim S; Chang YK; Kim YC
    Sci Rep; 2020 Dec; 10(1):22158. PubMed ID: 33335164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Knockout of the Vegfa Gene in the Retina by Subretinal Injection of RNP Complexes Containing Cas9 Protein and Modified sgRNAs.
    Holmgaard AB; Askou AL; Jensen EG; Alsing S; Bak RO; Mikkelsen JG; Corydon TJ
    Mol Ther; 2021 Jan; 29(1):191-207. PubMed ID: 33022212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea.
    Mirjalili Mohanna SZ; Djaksigulova D; Hill AM; Wagner PK; Simpson EM; Leavitt BR
    J Control Release; 2022 Oct; 350():401-413. PubMed ID: 36029893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scaffold-Based Delivery of CRISPR/Cas9 Ribonucleoproteins for Genome Editing.
    Chooi WH; Chin JS; Chew SY
    Methods Mol Biol; 2021; 2211():183-191. PubMed ID: 33336278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folate Receptor-Mediated Delivery of Cas9 RNP for Enhanced Immune Checkpoint Disruption in Cancer Cells.
    Lin Y; Wilk U; Pöhmerer J; Hörterer E; Höhn M; Luo X; Mai H; Wagner E; Lächelt U
    Small; 2023 Jan; 19(2):e2205318. PubMed ID: 36399647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quaternary ammonium-based nanosystem enables delivery of CRISPR/Cas9 for cancer therapy.
    Zhang M; Sun S; Liang X; Liu Z; Yin J; Li Q; Yang S
    Biomater Sci; 2024 Feb; 12(5):1197-1210. PubMed ID: 38240497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivering Cas9/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient 'hit-and-run' genome editing.
    Lyu P; Javidi-Parsijani P; Atala A; Lu B
    Nucleic Acids Res; 2019 Sep; 47(17):e99. PubMed ID: 31299082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finely tuned ionizable lipid nanoparticles for CRISPR/Cas9 ribonucleoprotein delivery and gene editing.
    Im SH; Jang M; Park JH; Chung HJ
    J Nanobiotechnology; 2024 Apr; 22(1):175. PubMed ID: 38609947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
    Li S; Song Z; Liu C; Chen XL; Han H
    ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo.
    Bykonya AG; Lavrov AV; Smirnikhina SA
    Mol Biotechnol; 2023 Feb; 65(2):181-195. PubMed ID: 35322386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
    Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
    Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editing the immune system in vivo in mice using CRISPR/Cas9 ribonucleoprotein (RNP)-mediated gene editing of transplanted hematopoietic stem cells.
    Wang R; Graham S; Gao L; Tam J; Levesque MC
    Methods; 2021 Oct; 194():30-36. PubMed ID: 33422676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.